Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading NanoViricides Inc chart...

About the Company

nanoviricides, inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. its products pipeline includes herpecide dermal topical and eye drops for the treatment of shingles, phn, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and herpecide intraocular injection for viral acute retinal necrosis. the company also develops flucide broad-spectrum anti-influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; nanoviricide eye drops for viral diseases of the external eye; denguecide for treatment of all types of dengue viruses; and hivcide that is an escape-resistant anti-hiv nanoviricide. in addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and herpecide program expansion drug projects for different herpes viruses for different indications. nanovir

Exchange

NYSE MKT LLC

Website

http://www.nanoviricides.com/

$M

Total Revenue

5

Employees

$19M

Market Capitalization

-1.68

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NNVC News

Nanoviricides Inc (NV3P.MU)

15d ago, source: Yahoo Finance

SHELTON, CT / ACCESSWIRE / February 1, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel ...

NanoViricides, Inc. (NNVC) Interactive Stock Chart - Yahoo Finance

1mon ago, source: Yahoo Finance

SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its ...

NanoViricides (NNVC) Price Target Increased by 23.81% to 6.63

23d ago, source: Nasdaq

NanoViricides Background Information (This description is provided by the company.) NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral ...

NanoViricides: Fiscal Q2 Earnings Snapshot

1mon ago, source: Times Union

SHELTON, Conn. (AP) — SHELTON, Conn. (AP) — NanoViricides Inc. (NNVC) on Wednesday reported a loss of $2.1 million in its fiscal second quarter. On a per-share basis, the Shelton, Connecticut ...

Nanoviricides Inc NV3P

28d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

NanoViricides Inc

26d ago, source: U.S. News & World Report

What Is a Registered Investment Advisor? RIAs aren't just for the wealthy anymore, and they have a fiduciary duty to put their clients' interests first.

Nanoviricides Inc (NV3P.BE)

2mon ago, source: Yahoo Finance

SHELTON, CT / ACCESSWIRE / January 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...